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introduction: Aging is accompanied by increased susceptibility to infection and age- 
associated chronic diseases. It is also associated with reduced vaccine responses, 
which is often attributed to immunosenescence and the functional decline of the immune 
system. Immunosenescence is characterized by a chronic, low-grade, inflammatory 
state termed inflammaging. Habitants of Mediterranean (MED) regions maintain good 
health into old age; often attributed to MED diets.
hypothesis: Adoption of a MED-diet by elderly subjects, in Norfolk (UK), may improve 
immune responses of these individuals and in particular, dendritic cell (DC) function.
experimental approach: A total of 120 elderly subjects (65–79 years old) recruited 
onto the Nu-AGE study, a multicenter European dietary study specifically addressing 
the needs of the elderly, across five countries, and were randomized to the control or 
MED-diet groups, for one year. Blood samples were taken pre- and post-intervention 
for DC analysis and were compared with each other, and to samples obtained from 
45 young (18–40 years old) subjects. MED-diet compliance was assessed using high 
performance liquid chromatography-with tandem mass spectrometry analysis of urine 
samples. Immune cell and DC subset numbers and concentrations of secreted proteins 
were determined by flow cytometric analysis.
results: As expected, reduced myeloid DC numbers were observed in blood samples 
from elderly subjects compared with young. The elevated secretion of the adipokine, 
resistin, after ex vivo stimulation of peripheral blood mononuclear cells from elderly 
subjects, was significantly reduced after MED-diet intervention.
conclusion: This study provides further evidence of numerical and functional effects 
of aging on DCs. The MED-diet showed potential to impact on the aging immune cells 
investigated and could provide an economical approach to address problems associ-
ated with our aging population.
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inTrODUcTiOn
With age there is a progressive decline in the functionality of the 
immune system, termed immunosenescence (1), which is defined 
by differences in biomarkers of the immune system between 
young and elderly subjects, and is associated with a detrimental 
outcome (2). This typically refers to a reduction in response to 
vaccinations and greater susceptibility to infection and age-asso-
ciated disease, such as cardiovascular disease (CVD), rheumatoid 
arthritis, type II diabetes (T2D), and cancer (2, 3). Many age-
associated diseases are accompanied by dysregulated immune 
function and excessive inflammation; termed inflammaging (4). 
“Inflammaging” is characterized by chronic production of pro-
inflammatory cytokines such as IL-6, tumor necrosis factor alpha 
(TNF-α), and IL-1β by immune cells (1) and is often associated 
with immunosenescence (3). The burden of immunosenescence 
is becoming more apparent with a projected 2.9 million increase 
in the number of people with two or more long term conditions 
by 2018, and the high incidence of CVD and T2D in the elderly, 
which are associated with inflammation (5). Further investiga-
tion is therefore needed to identify potential new interventions 
to alleviate immunosenescence.
Dendritic cells (DCs) are one of the major antigen presenting 
cell populations of the immune system and are considered the 
only cells that are capable of activating naïve T cells. DCs can be 
divided into two phenotypically and functionally distinct subsets; 
plasmacytoid DCs (pDCs) and myeloid DCs (mDCs). pDCs that 
express low levels of MHC II and costimulatory molecules, and 
express TLRs 7 and 9 and secrete large quantities of type I IFN (6). 
mDCs, or conventional DCs that sense tissue injury and phagocy-
tose and capture antigen for presentation to T cells, and migrate 
to lymphatic tissue to prime naïve T cell responses (6). However, 
recently, further subdivisions of human blood DCs have been sug-
gested, with a total of six populations of DC identified following 
single-cell RNA sequencing (7). With age, a number of studies have 
found reductions in the number of pDCs, while the numbers of 
mDCs remained comparable between young and elderly individu-
als (8–10). The reasons for this inconsistency are not known but 
may be related to different definitions of age (9–11) and the use of 
different methods for enumerating DCs (8–10, 12). Since DCs are 
crucial for the generation of adaptive immune responses, it seems 
plausible that there may be an effect on DCs with increasing host 
age which would influence downstream T and B cell responses.
Whilst diet is a significant factor in maintaining a healthy 
immune system, conflicting evidence exists for the impact dif-
ferent food groups [carbohydrates, protein, fatty acids (FAs) 
and phytochemicals] have on the aging immune system, with 
both beneficial and detrimental effects observed. FAs can both 
increase and decrease pro-inflammatory cytokine secretion by 
DCs (13–15), of which the type of FA is of principal importance. 
In addition, short-chain fatty acids and polyphenols have been 
demonstrated to reduce secretion of IL-6 and IL-12 by lipopoly-
saccharide (LPS)-stimulated monocyte-derived DCS (MoDCs) 
and murine derived DCs, respectively (16–18). While there is 
some evidence that dietary intake can influence cytokine secre-
tion by peripheral blood mononuclear cells (PBMCs) (19–21), 
this was not reproduced in other studies (22–24).
It is noteworthy that many diet-immune health studies to 
date, have investigated dietary components in isolation, or as 
encapsulated supplements. This ignores the real-life response 
after consumption of whole foods which needs to be considered 
along with any interactions occurring between different com-
ponents of the diet. The relatively few whole diet studies that 
have assessed immune cells, including expression of adhesion 
markers or cytokine secretion, have been short in duration 
(typically 3 months) and have predominantly been conducted in 
Mediterranean (MED) countries such as Spain or Italy (25–27). 
A limited number of studies have investigated the Okinawan 
diet and New Nordic Diet but currently there is no evidence of 
immune modulation (28–31). Based on the current evidence of 
the positive health benefits of the MED diet in reducing cardio-
vascular risk factors, and expression of inflammatory mediators 
(25–27, 32, 33), predominantly in an elderly population, this diet 
has the potential to improve immune health. We have therefore 
investigated the impact of aging on DC populations and their 
functionality, in addition to the impact of dietary intervention 
with a MED diet for 12 months on DC parameters in a healthy, 
elderly population residing in Norfolk, UK. For these analyses, 
healthy young subjects (18–40  years) were recruited onto the 
Im-AGE study to compare the impact of aging on immune 
function. While, the Nu-AGE study, which was a multicenter 
European dietary study, across five countries, recruited elderly 
subjects at the University of East Anglia (UEA) to investigate 
whether changing the diet to resemble a MED diet, could influ-
ence immune functions in these individuals.
MaTerials anD MeThODs
Participant recruitment
Forty-five young participants (18–40  years) were recruited to 
the Im-AGE study via the Norfolk and Norwich University 
Hospital phlebotomy department (REC reference 15/SW/0038) 
and were apparently healthy and free from current or recent 
(3 months) chronic disease. Exclusion criteria included recent 
changes to medications, type I diabetes (T1D), use of steroids 
or immunomodulatory medication, or antibiotic use either cur-
rently or within the previous 2 months. A total of 120 elderly 
participants (65–79 years) were recruited to the Nu-AGE project 
via the Clinical Research and Trials Unit (CRTU) at the UEA 
(REC reference 12/EE/0109) and were apparently healthy and 
free from current or recent (3  months) chronic disease. Sixty 
subjects were enrolled into each arm of the dietary interven-
tion. Exclusion criteria included recent changes to medications, 
T1D, using steroids or, taking antibiotics currently or within 
the previous 2  months. Both the Im-AGE and Nu-AGE stud-
ies were conducted in full compliance with the principles of 
the declaration of Helsinki (2013 version) and following good 
clinical practice. There were no conflicts of interest in relation 
to these studies.
subject Demographics
Nu-AGE study pre-baseline data were collected as a self-reported 
7-day food diary (7DD), a general questionnaire to provide 
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socioeconomic information, followed by anthropometric meas-
urements at baseline at the UEA CRTU. Data collection was 
repeated 1-year post-intervention. To improve accuracy of the 
diet diaries, photographs of common portion sizes and servings 
such as mugs, glasses, and spoons were provided. Additionally, a 
member of the study team attended a home visit to more accu-
rately assess portion sizes and typically consumed brands of foods 
or foods which may not be clearly identified in the diet diary. For 
the Im-AGE study a lifestyle questionnaire was completed by all 
participants.
control and MeD Diets
The study participants were randomly allocated into two groups, 
control and intervention; the control group were pro vided 
with a standard healthy living advice leaflet from the Bri tish 
Dietetic Association and asked to maintain their habi tual 
dietary intake. The participants within the intervention group 
were provided with dietary advice sheets and individual die-
tary advice by members of the study team at the CRTU at 
UEA to achieve the quantitative requirements for the Nu-AGE 
dietary intervention (Table S1 in Supplementary Material). 
This advice was based on the information provided within the 
7-day food records collected at baseline. Study participants 
randomized to the dietary intervention arm of the study 
were given extra virgin olive oil, wholegrain pasta and low 
fat margarine rich in MUFA and PUFA, freely throughout the 
study. The study team distributed these products to interven-
tion participants at baseline and 4 and 8  months, when the 
participants attended the CRTU, either for their baseline 
measurements or for their interim interview questionnaires 
to assess blood pressure, cognitive function, and physical 
function; data not shown.
Dual X-ray Bone Densitometer  
(DXa) scans
Bone mineral density (BMD) and bone composition were 
determined using whole body DXA scans (DXA Discovery Wi 
dual-energy X-ray absorbtiometer; Hologic Inc.), at pre- and 
post-intervention study visits (Nu-AGE study only), by a trained 
member of the study team and according to a standard protocol. 
BMD was measured at the lumbar spine and proximal femur.
Blood sample collection
For both studies 23 ml blood was taken by venipuncture; 3 ml with 
sodium heparin and 20 ml with EDTA (BD; Bunzl Healthcare) to 
obtain peripheral blood and PBMCs. PBMCs were isolated using 
Ficoll-Hypaque density gradient centrifugation (Sigma-Aldrich, 
density 1.077 g/ml). For functional assays, PBMCs were stored 
frozen in heat-inactivated fetal bovine serum (FBS) (Biosera) 
containing 10% dimethyl sulfoxide (Sigma-Aldrich) at −80°C 
before use. Further blood samples (total volume 100 ml) were col-
lected from all Nu-AGE volunteers at pre- and post-intervention 
visits to obtain plasma. The plasma was used for analysis of lipid 
profiles (total cholesterol, LDL cholesterol, HDL cholesterol, and 
triglycerides). Blood samples were processed or analyzed within 
4 h of collection.
Blood Dc enumeration
Dendritic cells were enumerated in whole blood using the Blood 
DC Enumeration Kit (Miltenyi-Biotec) according to the manu-
facturers’ instructions using the monoclonal antibodies (mAbs) 
CD1c-PE (Clone: AD5-8E7), CD303-FITC (Clone: AC144), 
CD14-PE-Cy5, CD19-PE-Cy5, and CD141-APC (Clone: AD5-
14H12). As controls, isotype matched mouse IgG2a-PE, IgG1-
FITC, IgG1-APC, Ig-G2a-PE-Cy5, and IgG1-PE-Cy5 antibodies 
were used. Flow-count™ fluorospheres (Beckman Coulter) were 
used to obtain absolute leukocyte counts. Data were acquired on 
the Beckman Coulter Cytomics FC500 MPL and the Sony EC800 
with a minimum of 1,000 events acquired within the flow count 
fluorosphere gate, and a minimum of 100,000 events acquired 
within the cell gate to exclude debris. Single-stained compensa-
tion controls, prepared using Ultracomp ebeads (Affymetrix 
eBioscience), and non-stained control samples were run on both 
cytometers to allow for manual compensation to be applied to 
all acquired sample data. Acquired data were analyzed using 
FlowJo™ software (TreeStar, San Carlos, CA, USA), Version 10. 
Data are presented from the Sony EC800 for both the Nu-AGE 
and Im-AGE studies, all samples were also run on the Beckman 
Coulter FC500 MPL to provide a back-up machine for techni-
cal failures of the Sony EC800. For each individual sample the 
absolute number of pDCs and mDCs per microliter of blood 
was calculated by subtracting the number of cells in the DC gate 
for the isotype control, from the count in the DC gate for the 
test sample. This number, for each subset, was then divided by 
the count of Flow-count™ fluorospheres and multiplied by the 
assayed concentration of the Flow-count™ fluorospheres; calcu-
lated by the manufacturer and provided with each lot of beads.
Functional analysis of Blood Dcs
Frozen PBMCs were thawed and cultured in tissue culture media 
[90% Roswell Park Memorial Institute 1,640 (Sigma-Aldrich), 
10% heat-inactivated FBS (Biosera), supplemented with l-glu-
tamine (2 mM), penicillin (100 U), and streptomycin (0.1 mg/ml) 
(all Lonza)] for 19 h at 37°C in 5% CO2 in 96 well flat bottom 
tissue culture plates (Sarstedt) to allow recovery. Viability of all 
thawed PBMC samples was determined using trypan blue viabil-
ity dye exclusion (0.4%; Sigma-Aldrich) and all samples were 
resuspended at a final concentration of 0.5 ×  106  cells/200  µl; 
to ensure that the same number of live cells were used in each 
culture. Before the addition of 1  µg/ml LPS (Invivogen) and 
2.5 µg/ml R848 (Invivogen), in the presence or absence of 2 µM 
monensin (Sigma-Aldrich) for 3 h. Non-stimulated controls were 
incubated with fresh tissue culture media, with or without 2 µM 
monensin. Cell culture supernatants were stored at −80°C before 
cytokine analysis. To detect cytokine synthesis by DCs, cultured 
cells were first incubated with Fc Receptor block (Miltenyi-
Biotec) for 25 min, at 4°C in the dark and then stained with anti-
CD1c-PE (Clone: AD5-8E7), anti-CD303-PE (Clone: AC144), 
anti-CD304-PE (Clone: AD5-17F6) (all from Miltenyi-Biotec), 
anti-CD3-FITC (Clone: UCHT1), anti-CD16-FITC (Clone: 
3G8) (Becton Dickinson), anti-CD14-FITC (Clone: TÜK4), anti-
CD19-FITC (Clone: LT19), and anti-HLA-DR-Alexa Fluor 700 
(Clone: L243) (all from BioLegend) antibodies. The correspond-
ing isotype controls IgG1-FITC (BioLegend), IgG2a-PE, IgG1-PE 
TaBle 1 | Baseline anthropometric data for Im-AGE and Nu-AGE participants.
im-age (n = 45) nu-age (n = 122) p value
Age (years) Mean (SD) 30.71 (6.36) 70.33 (4.16) <0.0001
Range 20–40 65–79
Gender % Female 57 61 0.8589 (ns)
Weight (kg) Mean (SD) 74.46 (14.02) 73.27 (13.85) 0.6676 (ns)
Range 53.98–108.0 49.50–128.50
Height (cm) Mean (SD) 169.30 (10.03) 165.70 (9.16) 0.0311
Range 147.30–191.00 145.60–188.20
BMI (kg/m2) Mean (SD) 26.13 (3.66) 26.62 (3.96) 0.7237 (ns)
Range 19.86–34.15 18.50–43.20
ns, not statistically significant; SD, standard deviation.
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(Miltenyi-Biotec), and IgG2-AF700 (BioLegend) were also used. 
Cells were then fixed and permeabilized using Leucoperm cell 
fixation and permeabilization reagents (AbD Serotec), then 
stained for intracellular cytokines with the mAbs IL-1β-PE-Cy7 
(Clone: JK1B-1), IL-6-Pacific Blue (Clone: MQ2-13A5), and 
CXCL8-Alexa-Fluor-647 (Clone: E8N1), or the corresponding 
isotype controls PE-Cy7-Mouse IgG1 and Alexa-Fluor-647-Rat 
IgG1 (all from BioLegend). Cells were incubated for 30 min at 
21°C, in the dark, washed with PBS/0.5% FBS then resuspended 
in flow cytometry buffer containing 1% formalin. Data were 
acquired on the BD LSR Fortessa cytometer. Spectral overlap 
that occurred between channels was manually compensated 
in FlowJo™ software Version 10, after measurement of single-
stained compensation controls prepared using Ultracomp ebeads 
(Affymetrix eBioscience) and unstained control samples. Data 
were analyzed using FlowJo™ software Version 10.
cytokine content of culture supernatants
Supernatants from PBMC cultures were analyzed for CXCL8, 
IL-1β, IL-6, monocyte chemoattractant protein-1 (MCP-1), TNF-
α, leptin, IL-10, adiponectin, adipsin, IFN-γ, IP-10 (CXCL10), 
RBP4, and resistin by multiplex immunoassay (LEGENDplex 
Human Adipokine panel; BioLegend) according to the manu-
facturers’ instructions. The standard provided within each kit 
was serially diluted (1:4) six times after the top standard (neat 
standard); in addition to assay buffer (zero standard). Each well 
contained sample or a standards dilution series and, after addition 
of the premixed beads and detection antibody, were resuspended 
in 300 µl wash buffer before acquiring data on the flow cytom-
eter (BD Fortessa X-20). Acquired data were analyzed using the 
BioLegend LEGENDplex software. Briefly, standard curves were 
produced for each of the 13 analytes to allow the concentrations 
of each analyte, within the samples measured, to be determined; 
based on mean fluorescence intensity values relating to known 
concentrations for serial dilution of the standards. The standard 
curves also provided validation for each experiment. Inter-plate 
variability was determined for experiments carried out on dif-
ferent days.
statistical analysis
Subject demographics of young and elderly subjects (at baseline) 
were compared using Mann–Whitney U tests, after carrying 
out D’Agostino and Pearson normality tests, using GraphPad 
Prism Version 7. Comparisons made between the baseline 
and post-intervention time points within each dietary group 
(control or MED-diet intervention) used paired t-tests. Blood 
mDC and pDC phenotypes were compared between elderly and 
young volunteers using a Welch–Satterthwaite t-test on rank 
transformed data. For mDC, the size of the difference (34) and 
the 95% confidence intervals (35) were estimated for a Wilcoxon 
Mann–Whitney U test. A Mann–Whitney U test was used to 
determine the presence of differences between the control and 
dietary intervention cohorts. GraphPad Prism Version 7 was 
used to determine the differences in proportions and cell counts 
of DCs which were positive for IL-6, CXCL8, and IL-1β secre-
tion between young and elderly subjects using Mann–Whitney 
U tests, after performing a D’Agostino and Pearson normality 
test to determine non-Gaussian distribution. Proportions and 
cell counts of DCs positive for IL-6, CXCL8 and IL-1β secretion 
at pre- to post-intervention for each intervention group were 
compared using Wilcoxon matched pairs signed rank tests, after 
performing a D’Agostino and Pearson normality test to determine 
non-Gaussian distribution. Post hoc analyses were performed by 
one-way analysis of variance (ANOVA) using the Kruskal–Wallis 
test with Dunn’s multiple comparisons post hoc test to identify 
any differences in proportions of single and double positive cells. 
GraphPad Prism Version 7 was used to deter mine interplate 
variability between multiplex immunoassays using repeated-
measures ANOVA. Differences in concentration of each analyte 
between unstimulated and stimulated samples were calculated 
using two-tailed paired t-tests, while differences in concentra-
tion change from unstimulated level between young and elderly 
subjects was determined using two-tailed Mann–Whitney U tests 
for each analyte. Differences in concentration from unstimulated 
were compared per group, pre- versus post-intervention using 
Mann–Whitney U tests. Comparison of change from baseline 
(CFB) between control and MED-diet groups was carried out 
using Mann–Whitney U tests.
resUlTs
subject Demographics of Young  
and elderly cohorts
Mean ages of the two groups were 30.71 years for the young and 
70.33 years for the elderly cohort (Table 1). Both groups contained 
a greater number of female participants although this was not 
significantly different. The mean weight and BMI of participants 
between groups was similar though the upper range of weights of 
the elderly cohort was greater than for the young group. When 
considering height there was a significant difference between the 
young and elderly groups, with the elderly having a lower mean 
value, which is relevant as losing height with age impacts BMI.
numbers of mDcs Were reduced in the 
elderly, while pDc numbers remained 
similar to Young subjects
To obtain an accurate comparison of DC subset counts between 
the two age groups with minimal sample processing, whole 
FigUre 1 | Myeloid DC (mDC) counts for the Im-AGE (young) and pre-intervention Nu-AGE (elderly) cohorts. Whole blood was stained with antibodies reactive with 
CD1c to identify mDCs, CD303 to identify pDCs, and to CD14 and CD19 to exclude CD14+ monocytes and CD19+ B cells, of which a high proportion express 
CD1c. n = 45 in the young cohort and n = 120 in the elderly cohort. Box and whisker plot of mDC (a) and pDC (B) counts for young and elderly subjects extending 
from the 25th to the 75th percentiles with the line through the box representing the median and plus (+) representing the mean value. Whiskers were determined 
using Tukey’s method using the 25th and 75th percentile plus 1.5 times the interquartile range (IQR) as the end of the whiskers. Dots represent individual 
participants where the values fell above the 25th or 75th quartile plus 1.5 times the IQR. Welch–Satterthwaite t-test on rank transformed data was used to 
determine the presence of differences between the young and elderly cohorts; significance assumed at P < 0.05, **P < 0.01, P = 0.0043 (mDCs) and P = 0.3108 
(pDCs).
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blood was used with an antibody panel comprising the blood 
DC specific markers CD1c and CD303, excluding CD14 and 
CD19 positive monocytes/macrophages and B cells, respectively. 
Comparing the young to the elderly cohort for the mDC phe-
notype there was sufficient evidence to reject the null hypoth-
esis of equal cell counts in each group. The young cohort had 
greater numbers of mDCs compared with the elderly cohort, 
with the difference estimated to be 0.4831 (0.1622, 0.7932; 95% 
confidence interval) with a corresponding significance level of 
P =  0.0043 (Figure  1A). However, when comparing the pDC 
phenotype between the young and elderly cohorts there was 
insufficient evidence to reject the null hypothesis of no difference 
between the cell counts in each group at the 5% significance level 
(P = 0.3108) (Figure 1B).
Dcs from elderly subjects Produce less 
cXcl8 and have Fewer Dcs Producing 
il-6+cXcl8+ and il-1β+cXcl8+
Intracellular staining (ICS) is a robust method for observing 
cytokine production by individual cell populations within a 
complex multicellular sample that obviates the need for further 
manipulation to isolate cells of interest (36, 37). As the study 
samples were collected over the period of 2.5 years, it was not 
possible, or appropriate, to use fresh PBMCs for these experi-
ments, therefore isolated PBMCs were cryopreserved before 
analysis.
Comparing DCs from young and elderly subjects showed 
that the proportion of CXCL8+ and IL-1β+CXCL8+ double 
positive cells was significantly greater amongst DCs derived 
from young subjects compared with those from elderly subjects. 
This was apparent both with and without LPS, R848 stimulation 
(Figures  2A,B). The proportion of DCs secreting IL-1β was 
not significantly different between samples derived from young 
and elderly subjects. In addition, there were significantly more 
CXCL8+IL-6+ DCs in samples derived from young subjects 
compared with those from the elderly, but only after LPS, R848 
stimulation (Figures  2C,D). The proportion of single positive 
DCs for CXCL8 (IL-6−CXCL8+) was significantly greater in 
samples from young subjects, while IL-6 single positive cells 
were not significantly different between the two groups; this 
was apparent for both non-stimulated and stimulated samples. 
Further analysis, by one-way ANOVA, identified significant 
differences in the proportion of non-stimulated IL-1β−CXCL8+ 
DCs and IL-1β+CXCL8− cells, as well as between CXCL8+IL-6+ 
and CXCL8−IL-6+ compared with CXCL8+IL-6− cells, and 
CXCL8−IL-6+ compared with CXCL8+IL-6− DCs, in LPS and 
R848-stimulated samples from young subjects. While in the DCs 
from elderly subjects the only significant differences observed 
were between the proportion of CXCL8+IL-6+ compared with 
CXCL8+IL-6− DCs in LPS and R848-stimulated samples.
Secretion of adipokines by PBMCs was significantly reduced 
in the elderly. Differences in secretion between baseline (non-
stimulated) and post-stimulation with LPS and R848 for young 
subjects, as determined by paired t-tests (Table  2) was signifi-
cantly different for MCP-1, IL-1β, IP-10, IL-10, CXCL8, IL-6, and 
TNF-α. However, differences in secretion by PBMCs from elderly 
subjects (Table 2) were only significant for IL-1β, CXCL8, IL-6, 
and TNF-α when comparing stimulated to non-stimulated sam-
ples. Comparison of cytokine secretion in samples from young 
to elderly subjects showed the levels of secretion were ~10-fold 
lower in samples from the elderly. To ensure accurate compari-
sons between samples any samples producing values below the 
level of detection were recorded as 0.0 pg/ml.
FigUre 2 | Scatter plots showing proportion of cytokine producing dendritic cells from young and elderly subjects. Peripheral blood mononuclear cells (PBMCs) 
were cultured in vitro for 3 h with tissue culture media alone (a,c) or in media containing lipopolysaccharide (LPS) and R848 (B,D) in the presence of 2 µM 
monensin. PBMC samples were subsequently surface stained with monoclonal antibodies against HLA-DR, CD1c, CD303, and CD304, CD14, CD16, CD19, and 
CD3, permeabilized and stained with anti-IL-1β, IL-6, and CXCL8 antibodies. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001 indicate significance between 
age groups as measured by Mann–Whitney U tests and post hoc analyses, performed by one-way analysis of variance using the Kruskal–Wallis test with Dunn’s 
multiple comparisons post hoc test to identify any differences in proportions of the three cell types. Error bars show SEM and a horizontal line at the mean. CXCL8, 
C-X-C chemokine ligand 8; IL, interleukin; LPS, lipopolysaccharide, R848, resiquimod.
6
Clements et al. DCs and Ageing with MED Diet
Frontiers in Nutrition | www.frontiersin.org December 2017 | Volume 4 | Article 65
Comparisons of the CFB after LPS and R848 stimulation 
between young and elderly subjects showed that the PBMCs 
from young subjects secreted higher concentrations of MCP-1, 
TNF-α, CXCL8, IL-1β, and IL-6 compared with those from 
elderly subjects, all of which were significantly greater (P < 0.05) 
(Table 2). By contrast, resistin secretion decreased after stimula-
tion of the PBMCs from the young subjects (mean of 29 donors), 
while secretion from PBMCs derived from elderly subjects was 
statistically higher compared with the young subjects (P = 0.028). 
Change in levels of adiponectin after LPS, R848 stimulation were 
not significantly different between young and elderly subjects 
(P = 0.814; data not shown).
To ensure that any changes observed between groups were 
independent of plate-to-plate variability, the absolute concentra-
tions for each serial dilution of the standards, which were run 
on every plate, were compared. Concentrations for all dilutions 
of the standard were comparable between all plates and all 
corresponded to the expected concentration, additionally, the 
coefficient of variance for each analyte on each plate were all 
within acceptable limits of less than 5%, highlighting the preci-
sion of each dataset (data not shown). All R2 values were ≥0.998.
In summary, we observed a significant reduction in numbers 
of mDCs within peripheral blood, in addition to significantly 
reduced secretion of pro-inflammatory cytokines (IL-1β, CXCL8, 
IL-6, TNF-α, and MCP-1), and elevated secretion of resistin upon 
TLR stimulation by DCs and PBMCs, respectively. The potential 
for MED-dietary intervention to impact on these findings was 
investigated in elderly individuals over a 1-year period.
Demographics of MeD-Diet intervention 
Participants
Both MED diet and control groups had lower mean BMI (−0.3 kg/m2) 
and weight (−0.5 kg) values after the year intervention; however, 
TaBle 2 | Mean concentrations for each adipokine in cell culture supernatants 
from peripheral blood mononuclear cells with or without lipopolysaccharide, 
R848 stimulation from young and elderly subjects.
adipokine age group Media alone  
(pg/ml)
stimulated  
(pg/ml)
P value
MCP-1 Young Mean  
(SEM)
1,237 (279.00) 1,507 (315.90) 0.004
Range 1.2–7,054 1.24–8,080
Elderly Mean  
(SEM)
11.24 (3.37) 22.05 (8.40) 0.065 (ns)
Range 0–57.54 0–199.90
IL-1β Young Mean  
(SEM)
334.70 (191.00) 519.10 (149.40) 0.049
Range 0–4,304 0–3,217
Elderly Mean  
(SEM)
1.12 (0.53) 11.38 (3.36) 0.005
Range 0–9.49 0–52.37
IP-10 Young Mean  
(SEM)
144.60 (96.79) 302.10 (130.60) 0.001
Range 0–2,830 1.28–3,617
Elderly Mean  
(SEM)
2.37 (0.83) 2.14 (0.89) 0.670 (ns)
Range 0–17.14 0–21.72
IL-10 Young Mean  
(SEM)
18.89 (7.76) 40.73 (8.84) 0.006
Range 0–178.90 0–149.90
Elderly Mean  
(SEM)
0.08 (0.05) 0.13 (0.08) 0.166 (ns)
Range 0–1.24 0–1.85
CXCL8 Young Mean  
(SEM)
2,987 (458.10) 4,998 (742.30) 0.003
Range 5.36–8,231 5.12–15,430
Elderly Mean  
(SEM)
115.30 (61.45) 346.10 (118.30) 0.007
Range 0–1,610 0–2,422
IL-6 Young Mean  
(SEM)
529.70 (229.50) 1,392 (240.10) 0.001
Range 0–4,880 0–4,470
Elderly Mean  
(SEM)
2.34 (2.06) 15.43 (7.64) 0.034
Range 0–53.43 0–187.40
Resistin Young Mean  
(SEM)
169.40 (42.51) 140.90 (40.04) 0.054
Range 0–998.40 1.43–991.40
Elderly Mean  
(SEM)
121.60 (51.93) 136.40 (54.34) 0.264 (ns)
Range 0–1,028 0–869.90
TNF-α Young Mean  
(SEM)
81.06 (49.42) 2,782 (459.60) <0.0001
Range 0–1,207 0.9–7,550
Elderly Mean  
(SEM)
0.77 (0.59) 48.27 (16.41) 0.008
Range 0–15.42 0–350.90
CXCL8, C-X-C chemokine ligand 8; IL, interleukin; IP, interferon gamma inducible 
protein 10; ns, not statistically significant; MCP-1, monocyte chemoattractant 
protein-1; SEM, standard error of the mean; TNF-α, tumor necrosis factor alpha.
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The results of DXA scans at baseline and 1-year post-intervention 
show that there were minimal changes to the mean body weight, 
fat mass, lean mass, bone mineral content (BMC), soft tissue 
and BMD, while the fat mass and regional fat mass percentages 
were reduced at post-intervention but minimally (Table S2 in 
Supplementary Material). The mean T scores were similar but 
the upper value of the range was much smaller, indicating dete-
rioration in some subjects (Table S2 in Supplementary Material). 
Plasma lipid analysis shows that while all subjects had high total 
and LDL cholesterol, and normal HDL and triglyceride concen-
trations, these concentrations were unaffected in both dietary 
groups (Figure S2 in Supplementary Material).
Diet had no effect on Dc subset 
Distribution or cytokine Production  
in elderly subjects
No effect was observed in numbers of either mDC (Figure 3A) 
or pDC (Figure  3B) subsets, which remained consistent over 
the dietary intervention for both groups. There was therefore 
insufficient evidence to reject the null hypothesis of no differ-
ence between the cell counts in each group at the 5% significance 
level.
Significant reductions in IL-1β+CXCL8+ DCs were observed 
between pre- and post-intervention in the control group 
with LPS, R848 stimulation (Figure  4B; P =  0.0264). Also, a 
significant reduction was observed in CXCL8−IL-6+ DCs in 
non-stimulated samples from the control group (Figure  4C; 
P = 0.0269). Further analysis (by one-way ANOVA) showed the 
numbers of IL-1β−CXCL8+ DCs were significantly greater than 
the number of IL-1β+CXCL8+ DCs at post-intervention in non-
stimulated samples (Figure  4A; P =  0.0146) and the numbers 
of CXCL8+IL-6+ DCs at post-intervention were significantly 
reduced compared with CXCL8+IL-6− DCs at post-intervention 
(Figure 4D; P = 0.0380), after LPS, R848 stimulation.
In the MED-diet group, no significant differences were 
observed on comparison of the same cell type from pre- to post-
intervention in LPS, R848-stimulated or non-stimulated samples 
(P >  0.05). After further analyses significant reductions were 
observed in CXCL8+IL-6+ compared with CXCL8+IL-6− DCs 
both at pre- (P = 0.0118) and post-intervention (P = 0.0154) for 
unstimulated samples. The same was also observed in LPS, R848-
stimulated samples (P = 0.0051 and P = 0.0008 respectively), in 
addition significantly greater numbers of IL-1β−CXCL8+ DCs at 
pre- and post-intervention compared with IL-1β+CXCL8− DCs at 
post-intervention (P = 0.0105 and <0.0001; respectively).
The MeD-Diet reduced resistin 
Production by PBMcs
There were no significant differences in secretion of any of the 
cytokines analyzed in the control group by non-stimulated or 
LPS, R848-stimulated PBMCs at baseline (Table 4) as determined 
by paired t-tests. While in the MED-diet group LPS, R848 stimu-
lation induced significant increases in IL-1β, CXCL8, and TNF-α 
secretion (Table 5). The absolute concentrations recorded for the 
two groups at baseline were similarly low for Adipsin, MCP-1, 
IP-10, IL-6 (Table 5), and IFN-γ (data not shown).
comparison of the CFB between the two groups was not sig-
nificantly different for either variable. Similarly, height, waist 
circumference, and frailty status changes from baseline were 
comparable with no significant difference observed between the 
groups at post-intervention (Table 3). Ten participants dropped 
out of the study; however, the gender ratios of the two groups 
remained similar at post-intervention, with no significant differ-
ence observed between the groups at post-intervention (Table 3). 
FigUre 3 | Myeloid DC (mDC) and plasmacytoid DC (pDC) counts after dietary intervention for control and MED diet study groups. Whole blood from control and 
dietary intervention groups was stained with anti-CD1c to identify mDCs, CD303 to identify pDCs, and anti-CD14 and CD19 to exclude CD14+ monocytes and 
CD19+ B cells, of which a high proportion express CD1c. The data show box and whisker plots of change in mDC (a) and pDC (B) counts from pre- to post-
intervention in elderly subjects extending from the 25th to the 75th percentiles, with the horizontal line representing the median. Whiskers were determined using 
Tukey’s method using the 25th and 75th percentile plus 1.5 times the interquartile range (IQR) as the end of the whiskers. Squares represent individual participants 
where the values fell above the 25th or 75th quartile plus 1.5 times the IQR. A Mann–Whitney U test was used to determine the presence of differences between the 
control and dietary intervention cohorts. n = 58, Control group, n = 62, Mediterranean (MED)-diet group, significance assumed at *P < 0.05, **P < 0.01, P = 0.9104 
(mDCs) and P = 0.3553 (pDCs).
TaBle 3 | Characteristics of study participants at pre-compared to post-intervention.
Pre-intervention Post-intervention Mean cFB in 
control group
Mean cFB in 
MeD group
P values (control 
v MeD diet)
control group 
(n = 57)
Mediterranean (MeD)-
diet group (n = 65)
control group 
(n = 54)
MeD-diet group 
(n = 61)
Age (years) Mean (SD) 71.0 (4.1) 69.8 (4.2) 71.6 (3.8) 70.8 (4.2) 0.6 1.0 0.55
Range 65–79 65–79 66–80 66–80
Gender % Female 61 60 61 57 0 −3 –
BMI (kg/m2) Mean (SD) 26.6 (3.3) 26.7 (4.5) 26.3 (3.6) 26.4 (4.6) −0.3 −0.3 0.99
Range 20.0–37.4 18.5–43.2 18.9–37.9 18.2–45.8
Weight (kg) Mean (SD) 73.2 (12.5) 73.4 (15.1) 72.7 (12.6) 72.9 (14.7) −0.5 −0.5 0.40
Range 52.5–108.9 49.5–128.5 52.0–101.0 49.7–118.7
Height (cm) Mean (SD) 165.7 (9.3) 165.6 (9.1) 166.1 (9.3) 165.8 (9.0) 0.4 0.2 0.26
Range 148.6–187.4 145.6–188.2 149.6–186.5 146.6–187.1
Waist  
circumference (cm)
Mean (SD) 91.5 (11.1) 91.3 (12.5) 91.2 (11.7) 91.5 (12.6) −0.3 0.2 0.96
Range 72.0–122.0 63.5–134.8 69.1–127.9 65.0–126.7
Frailty status (n) Non-frail 12 14 9 9 1 12 0.62
Pre frail 44 50 42 54 −4 −7
Frail 2 0 0 0 −0.04 0
P values determined by paired t-tests.
CFB, change from baseline; MED-diet, mediterranean diet; SD, standard deviation.
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At post-intervention (Table 4) in the control group the secre-
tion of IL-1β and TNF-α were significantly increased after LPS, 
R848 stimulation. The concentration of resistin was significan-
tly reduced post-MED dietary intervention (Table 5). All other 
analytes remained the same, with no significant differences obser-
ved between non-stimulated and LPS, R848-stimulated PBMC 
samples.
Comparison of PBMC cytokine secretion from pre- to post-
intervention showed that all analytes investigated, except for 
resistin, were not significantly affected by dietary intervention 
(Figures 5A–D). Comparing changes in resistin concentration, 
between LPS, R848-stimulated pre- and post-intervention 
for each group revealed that while the resistin levels were not 
significantly different between the pre- and post-intervention 
sample in the control group, they were significantly reduced 
at post-intervention in the MED-diet group (Figure  5C). 
However, upon comparison of the CFB between the control 
and MED groups, it was apparent that the change in resistin 
FigUre 4 | Cytokine producing dendritic cells from elderly subjects at pre- and post-dietary intervention. Peripheral blood mononuclear cells from control subjects 
and Mediterranean (MED)-diet intervention subjects were cultured for 3 h in complete tissue culture media alone (a,c), or in media containing lipopolysaccharide 
(LPS) and R848 (B,D) in the presence of 2 µM monensin. Samples were subsequently surface stained with anti-HLA-DR, CD1c, CD303, and CD304, CD14, CD16, 
CD19, and CD3 antibodies, permeabilized and stained with anti-IL-1β IL-6 and CXCL8 antibodies. Squares represent values for each individual subject with filled 
squares (■) representing pre-intervention values and open squares (□) representing post-intervention values. Significance assumed at P < 0.05; *P < 0.05, 
**P < 0.01, ***P < 0.001, and ****P < 0.0001 indicates significance between pre- and post-dietary intervention as measured by Wilcoxon matched pairs signed rank 
test, and post hoc analyses, performed by one-way analysis of variance using the Kruskal–Wallis test with Dunn’s multiple comparisons post hoc test to identify any 
differences in proportions of the three cell types. Error bars show SEM and a horizontal line at the mean. CXCL8, C-X-C chemokine ligand 8; IL, interleukin; LPS, 
lipopolysaccharide, R848, resiquimod.
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secretion, after LPS, R848 stimulation, was not significantly 
different between the two groups (Figure 6C). Similarly, CFB 
in CXCL8 was not significantly different between the control 
and MED-diet groups (Figure 6B), while CFB in MCP-1 and 
TNF-α were significantly different between control and MED-
diet subjects (Figures 6A,D).
MeD-Diet scores Were not Different 
between control and MeD-Diet study 
Participants but MeD-Diet subjects 
consumed More Phenolic compounds
To assess compliance self-reported 7DDs were kept at baseline 
and post-intervention by the study participants, which allowed 
MED-diet scores to be calculated for each participant, pre- and 
post-intervention, according to the method described by Sofi 
et al. (38). The mean MED-diet score for the control group was 
5.8, and for the MED-diet group was 5.5 at pre-intervention. In 
both groups, the mean scores decreased at post-intervention, to 
4.7 and 5.1, respectively (Table S3 in Supplementary Material). 
When comparing mean change in MED-diet scores from 
baseline for the two groups, the control group decreased, on 
average by one point, while there was little change in the MED-
diet group. Despite the significant difference observed between 
the mean change in MED-diet scores between the two study 
groups (Figure S2 in Supplementary Material), there was no 
evidence of an association between score and group allocation 
since the MED-diet score did not increase for the subjects in 
the MED-diet group.
To ascertain a biologically determined indication of study 
participants’ compliance, the levels of the olive oil metabolite, 
hydroxytyrsol sulfate (HTS), in 24-h urine samples collected 
from a subset of the Nu-AGE participants were analyzed, accord-
ing to ion fragmentation by HPLC coupled with tandem MS. 
The data show, surprisingly, that HTS was present in all samples 
at baseline, with a minimum concentration of 90 ng/ml. Upon 
grouping the samples according to study group allocation, control 
or intervention, the MED-diet group showed a greater increase 
from baseline in concentration of HTS, with 11 out of the 17 
participants showing an increase as opposed to a decrease from 
TaBle 5 | Absolute concentrations of cytokines in peripheral blood mononuclear 
cell culture supernatant, from elderly subjects in the Mediterranean-dietary 
intervention group, at pre- and post-intervention.
adipokine study time point Media alone stimulated P values
Adipsin Pre-int Mean 
(SEM)
3.83 (2.12) 4.74 (3.89) 0.743 (ns)
Range 0–23.14 0–57.72
Post-int Mean 
(SEM)
103.40 (48.23) 92.73 (48.59) 0.132 (ns)
Range 0–661.30 0–651.00
MCP-1 Pre-int Mean 
(SEM)
16.19 (5.12) 33.22 (13.63) 0.093 (ns)
Range 0–57.54 0–199.90
Post-int Mean 
(SEM)
199.80 (183.30) 179.20 (166.00) 0.264 (ns)
Range 0–2,398 0–2,170
IL-1β Pre-int Mean 
(SEM)
0.59 (0.54) 16.37 (5.25) 0.009
Range 0–8.17 0–52.37
Post-int Mean 
(SEM)
41.26 (30.94) 16.57 (11.54) 0.447 (ns)
Range 0–401.60 0–152.20
IP-10 Pre-int Mean 
(SEM)
0.73 (0.33) 1.30 (0.61) 0.225 (ns)
Range 0–4.28 0–7.67
Post-int Mean 
(SEM)
30.97 (28.74) 9.89 (7.62) 0.338 (ns)
Range 0–375.70 0–101.00
CXCL8 Pre-int Mean 
(SEM)
175.80 (104.20) 523.40 (191.30) 0.018
Range 0–1,610 7.07–2,422
Post-int Mean 
(SEM)
810.60 (395.90) 961.10 (480.10) 0.226 (ns)
Range 0–4,738 17.27–6,130
IL-6 Pre-int Mean 
(SEM)
3.69 (3.56) 23.89 (12.82) 0.056 (ns)
Range 0–53.43 0–187.40
Post-int Mean 
(SEM)
218.60 (208.80) 15.71 (6.24) 0.342 (ns)
Range 0–2,723 0–64.81
Resistin Pre-int Mean 
(SEM)
89.80 (53.89) 101.70 (60.39) 0.204 (ns)
Range 0–747.20 0–790.70
Post-int Mean 
(SEM)
304.60 (110.40) 251.10 (101.80) 0.049
Range 14.03–1,320 12.98–1,262
TNF-α Pre-int Mean 
(SEM)
1.28 (1.02) 71.44 (26.68) 0.021
Range 0–15.42 0–350.90
Post-int Mean 
(SEM)
394.20 (393.10) 18.35 (6.57) 0.360 (ns)
Range 0–5,111 0–64.89
CXCL8, C-X-C chemokine ligand 8; IL, interleukin; IP-10, interferon gamma inducible 
protein 10 LPS, lipopolysaccharide; ns, not statistically significant; MCP-1, monocyte 
chemoattractant protein-1; R848, resiquimod; SEM, standard error of the mean; TNF-
α, tumor necrosis factor alpha.
TaBle 4 | Absolute concentrations of cytokines in peripheral blood mononuclear 
cell culture supernatant, from elderly subjects in the control dietary intervention 
group, at pre- and post-intervention.
adipokine study time 
point
Media alone stimulated P values
Adipsin Pre-int Mean 
(SEM)
21.28 (9.66) 25.13 (10.8) 0.551 (ns)
Range 0–98.29 0–91.65
Post-int Mean 
(SEM)
96.99 (62.22) 89.06 (58.75) 0.076 (ns)
Range 0–710.70 0–669.50
MCP-1 Pre-int Mean 
(SEM)
4.50 (3.02) 6.81 (4.69) 0.205 (ns)
Range 0–34.13 0–52.88
Post-int Mean 
(SEM)
16.48 (6.70) 29.77 (12.53) 0.177 (ns)
Range 0–71.79 1.11–121
IL-1β Pre-int Mean 
(SEM)
1.83 (1.01) 4.58 (2.49) 0.275 (ns)
Range 0–9.49 0–25.03
Post-int Mean 
(SEM)
25.69 (17.19) 29.22 (17.06) 0.026
Range 0–153.70 0–158.90
IP-10 Pre-int Mean 
(SEM)
4.59 (1.75) 3.29 (1.93) 0.227 (ns)
Range 0–17.14 0–21.72
Post-int Mean 
(SEM)
1.35 (0.59) 1.32 (0.60) 0.963 (ns)
Range 0–5.17 0–5.73
CXCL8 Pre-int Mean 
(SEM)
32.84 (19.74) 104.4 (52.48) 0.065 (ns)
Range 0–220.70 0–580.50
Post-int Mean 
(SEM)
318.5 (185.80) 552.10 (169.80) 0.070 
Range 3.48–1,751 4.87–1,668
IL-6 Pre-int Mean 
(SEM)
0.50 (0.50) 3.90 (2.83) 0.185 (ns)
Range 0–5.48 0–29.38
Post-int Mean 
(SEM)
32.38 (22.26) 33.60 (19.39) 0.761 (ns)
Range 0–214.30 0–181.10
Resistin Pre-int Mean 
(SEM)
164.90 (100.30) 183.70 (100.5) 0.531 (ns)
Range 0–1,028 0–869.90
Post-int Mean 
(SEM)
309.10 (124.00) 285.10 (120.70) 0.124 (ns)
Range 0–1,245 0–1,246
TNF-α Pre-int Mean 
(SEM)
0.09 (0.09) 16.68 (7.67) 0.054 (ns)
Range 0–0.96 0–75.91
Post-int Mean 
(SEM)
2.95 (2.01) 53.26 (16.63) 0.016
Range 0–18.85 0–151
CXCL8, C-X-C chemokine ligand 8; IL, interleukin; IP-10, interferon gamma inducible 
protein 10; LPS, lipopolysaccharide; ns, not statistically significant; MCP-1, monocyte 
chemoattractant protein-1; R848, resiquimod; SEM, standard error of the mean; TNF-
α, tumor necrosis factor alpha.
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baseline levels (data not shown). When HTS concentrations were 
compared using an unpaired t-test (Figure S3 in Supplementary 
Material) there was strong evidence that HTS concentrations 
differed between the two groups (P <  0.05). In addition, the 
group with the higher levels of HTS was also the group which 
was found to consume significantly greater quantities of olive oil, 
determined when analyzing data from their 7DDs.
DiscUssiOn
numbers of mDcs are reduced in the 
elderly, while pDc numbers remain 
similar to Young subjects
Our finding that the reduction of mDCs but not pDCs with 
age is supported by Della Bella et  al. (12) who also analyzed 
FigUre 5 | Change in cytokine production by peripheral blood mononuclear cells (PBMCs) in response to lipopolysaccharide (LPS) and R848 stimulation 
in pre- versus post-dietary intervention. PBMCs from control subjects and Mediterranean (MED)-diet intervention subjects were cultured for 3 h in complete tissue 
culture media alone, or in media containing LPS and R848 in the presence of 2 µM monensin. PBMC culture supernatants were analyzed by multiplex bead based 
immunoassay to determine absolute concentrations of MCP-1 (a), CXCL8 (B), resistin (c) and TNF-α (D) in the PBMC samples. Concentrations (pg/ml) in 
non-stimulated samples were subtracted from stimulated samples to give a change in concentration as a result of the stimulus. Squares represent individual values 
for change in secretion of each cytokine by PBMCs, error bars represent the SEM. Determination of significant differences between pre- and post-intervention by 
paired t-tests, significance assumed at *P < 0.05, **P < 0.01, ***P < 0.001. CXCL8, C-X-C chemokine ligand 8, MCP-1, monocyte chemoattractant protein-1 ns; 
not statistically significant; TNF-α, tumor necrosis factor alpha.
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whole peripheral blood samples, in contrast to other studies 
using PBMCs that found reductions in pDCs (8, 10, 39). This 
discrepancy could be due to sample manipulation as suggested 
by Gerrits et  al. (40) who compared fresh blood samples to 
Ficoll-isolated fresh and cryopreserved PBMCs using anti-
CD1c, anti-CD303, anti-CD19, and anti-CD14 antibodies and 
found that PBMC isolation resulted in an approximate threefold 
increase in mDCs and pDCs when compared with fresh blood, 
and cryopreservation produced a fivefold increase. A previous 
study using very similar methodology to that described here 
produced opposing results (9). A possible reason for this may 
be that identification of CD1c and CD303 expressing blood 
DCs by Pérez-Cabezas et al. (9) did not exclude CD14, CD19, 
or CD20 and may have therefore overestimated mDCs numbers; 
B cells also express CD1c (41) and CD14+ monocytes present 
in PBMCs after CD19 depletion express CD1c (42). As we only 
show reductions in mDC counts it seems unlikely that this is 
a result of defective DC precursors with increased age, since 
both pDCs and mDCs are derived from macrophage and DC 
precursors and differentiate into common DC precursors (43). 
However, with regard to the reduction in mDCs, the finding of 
increased numbers of CD14+ monocytes and decreased num-
bers of CD34+ precursors (hematopoietic stem cells) alongside 
the reduction in mDCs by Della Bella et al. (12) implies there 
may be an age-associated impact on the differentiation of these 
cells, preventing DC differentiation. However, as this was not 
investigated here these findings cannot be confirmed in the 
Norfolk cohort.
FigUre 6 | Change from baseline (CFB) in cytokine production by PBMCs in response to lipopolysaccharide (LPS) and R848 stimulation after 1 year of control and 
MED-diet intervention. PBMCs from control subjects and MED-diet intervention subjects were cultured for 3 h in complete tissue culture media containing LPS and 
R848 in the presence of 2 µM monensin. PBMC culture supernatants were analyzed by multiplex bead based immunoassay to determine absolute concentrations 
of MCP-1 (a), CXCL8 (B), resistin (c) and TNF-α (D) in the PBMC samples. Concentrations (pg/mL) of each cytokine at pre-intervention were subtracted from the 
post-intervention values to give a CFB value. CFB in the control and MED-diet groups was compared using a Mann–Whitney U test, with significance assumed at 
*P < 0.05. CFB, change from baseline; CXCL8, C–X–C chemokine ligand 8; MCP-1, monocyte chemoattractant protein-1; MED: Mediterranean; PBMC, peripheral 
blood mononuclear cell; TNF-α, tumor necrosis factor alpha.
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Dcs from elderly subjects Produce less 
cXcl8 and have Fewer Dcs Producing 
il-6+ cXcl8+ and il-1β+ cXcl8+
The proportions of DCs secreting CXCL8 alone or in combina-
tion with IL-1β or IL-6 are significantly reduced with age 
after stimulation with LPS and R848. The highest proportion 
of cytokine secretion by DCs derived from both young and 
elderly donors is seen for CXCL8+IL-6− producing DCs. The 
results from non-stimulated and stimulated DCs are similar, 
except no statistically significant difference is observed 
between CXCL8+IL-6+ DCs from young and elderly subjects. 
A similar study using frozen PBMCs as a source of DCs for 
ICS (44) showed that, after 6 h stimulation with 0.5 µg/ml of 
LPS, DCs from elderly subjects produced significantly greater 
amounts of IL-6 (and TNF-α) than the non-stimulated cells 
with the increase being small but statistically significant. In 
this study Janssen et al. (44) recruited cytomegalovirus (CMV) 
seropositive young subjects, to exclude CMV seropositivity as 
a confounding factor when comparing results with elderly 
individuals; this could explain the differing results observed 
between this and our study.
We acknowledge that the differing results could also be a result 
of the length of time that the PBMCs were stimulated since in 
addition to use of a different source of DCs, increases in secretion 
of IL-6 from MoDCs have been observed with LPS stimulation 
(45, 46) for 24 and 48 h, respectively. The kinetics of DC cytokine 
secretion has been investigated to show that while DCs “exhaust” 
their capacity to produce IL-12 after long stimulation periods 
(such as 24 and 48 h), capacity to secrete IL-6 remained intact, 
even at 48  h (47), and could be detected after just 3–4  h. The 
reduction in mDC numbers observed in the elderly cohort com-
pared with the young cohort, may also be a contributing factor to 
the reduction in cytokine secretion observed in this study.
Secretion of Adipokines by PBMCs Is Significantly 
Reduced in the Elderly
We found significant reductions in MCP-1, TNF-α, CXCL8, 
IL-6, and IL-1β in PBMCs from elderly subjects. A similar study 
comparing cell culture supernatants from MoDCs stimulated 
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with LPS (for 20–24 h) found significantly increased concentra-
tions of IL-6 and TNF-α with single-stranded RNA stimulation 
also significantly increasing TNF-α secretion in the MoDCs 
from elderly subjects (46). However, mDCs and pDCs isolated 
from PBMCs of young and elderly subjects and stimulated with 
poly I:C and influenza virus, respectively, found that pDCs 
secreted less IFN-α, IL-6, and TNF-α compared with young 
con trols, while mDCs secreted comparable levels of cytokines 
(8). In addi tion, after 24 h LPS stimulation of PBMCs, but not 
whole blood, IL-6, CXCL8, and IL-1β secretion decreased (48), 
and in whole blood supernatants IL-1β and TNF-α secretion 
declined in samples from elderly compared with young sub-
jects (49). Therefore, the source of cell samples may again be a 
determining factor in whether cytokine secretion increases or 
decreases upon TLR stimulation.
resistin secretion by PBMcs increases 
with age
The present finding of significantly increased resistin produc-
tion, by LPS and R848 stimulated PBMCs from elderly compared 
to young subjects, after LPS and R848 stimulation is interesting 
since inflammatory events can induce resistin production (50). 
Resistin, in humans, is expressed predominantly in the bone 
marrow (BM) but is also present in circulating blood (51) and 
PBMCs are an important source (52). Our finding of increased 
resistin production by PBMCs from elderly subjects implies a 
potential underlying inflammatory state or inflammaging. LPS 
has been shown to increase resistin gene expression from human 
PBMCs while these data are only based on samples from three 
healthy volunteers, the increases in resistin were substantial and 
consistent between all volunteers (53); a more quantitative meas-
ure, such as a cytokine bead array, would aid in the explanation. 
Resistin has also been shown to suppress the ability of MoDCs 
to secrete IL-6, TNF-α, and IL-12 (p40) after incubation with 
lipoteichoic acid (LTA) from Staphylococcus aureus (54). This 
suggests that the observed decreases in IL-6 and TNF-α, and 
possibly the other cytokines in this study could have been due to 
the elevated secretion of resistin in the elderly subjects. Contrary 
to these findings, previous research has shown that plasma 
concentrations of resistin in a healthy population of over 250 
subjects did not differ with donor age (55). This may have been 
because the recruited cohort were healthy as previous observa-
tions of higher serum levels of resistin were also associated with 
increasing risk of CVD events (56). Resistin is also influenced 
by insulin resistance and adiposity, which was demonstrated 
upon comparison of offspring of non-long-lived individuals and 
centenarians (57).
When considering the two cohorts of volunteers recruited 
for this study there were no significant differences in mean 
BMI or weight of the individuals. After identifying individuals 
exhibiting increases in resistin PBMC secretion levels, BMI or 
weight were not consistently high for these individuals. In fact, 
out of the four individuals identified only one had a high BMI 
(pre-obese) (27.1 kg/m2), the rest were within the normal range 
(18.50–24.99 kg/m2) (58) and the highest concentration recorded 
was by an elderly individual with a healthy BMI of 23.0 kg/m2. 
Similarly, the DXA scan results from the elderly subjects also 
show that the individuals with the highest resistin concentra-
tions had a range of fat mass percentages from 19.2 to 39.8% 
and fat/lean mass ratios of 0.2 to 0.7. This implies that while 
adiposity is commonly attributed with elevated resistin levels 
this may not be the cause of the observed increase in resistin 
in this study. Although increases in body fat and reductions in 
fat free mass occur with age and differences were only seen in 
resistin concentration when subjects were grouped by body fat 
content as opposed to BMI (55).
The impact of this finding, in addition to the current 
understanding of resistin in terms of healthy aging, implies that 
preservation of insulin sensitivity with increased age may be of 
importance to preserve health of the elderly. Resistin suppresses 
secretion of IL-6, IL-12, and TNF-α by LTA-stimulated MoDCs 
(54) with IL-6 and a proliferation-inducing ligand being impor-
tant for maintenance of long-lived plasma cells, which decrease 
with age (59). Therefore, the age-associated reductions observed 
in cytokine secretion (IL-6, CXCL8, and IL-1β) but increases in 
the adipokine, resistin, could be due to an inflammatory state, 
typical of inflammaging.
Diet has no effect on Dc subset 
Distribution in elderly subjects
Our observation that the MED diet has no effect on mDC or 
pDC numbers contrasts with the finding of Rehman et al. (60) 
that showed inhibited production of both murine derived BM 
DCs and human PBMC derived MoDCs upon blocking of FA 
synthesis using an inhibitor of acetyl CoA carboxylase (TOFA). 
However, the consistency in DC numbers from both subsets at 
1-year post-intervention may be a positive finding as the numbers 
of mDCs or pDCs do not decrease further with an additional 
year of age. This has not been explored in previous studies that 
relied on one-off blood or PBMC samples from young and elderly 
subjects.
The MeD-Diet changes Dc cytokine 
secretion
The MED diet had no impact on DC cytokine secretion after 
1-year intervention. However, significant differences were 
observed between pre- and post-MED-diet intervention 
between CXCL8+IL-6+ and CXCL8+IL-6− DCs, IL-1β−CXCL8+ 
and IL-1β+CXCL8− DCs, after LPS, R848 stimulation. While 
secretion of CXCL8 was seen to decrease with age, post-MED 
diet CXCL8 secretion increases, with significantly greater propor-
tions of CXCL8+IL-6− DCs compared with CXCL8+IL-6+ DCs, 
as well as greater proportions of IL-1β−CXCL8+ DCs compared 
with IL-1β+CXCL8− DCs. These differences may be indicative of 
EPA and DHA (from consumption of oily fish) since these FAs 
diminish IL-6 secretion by LPS-stimulated MoDCs, with DHA 
treatment providing the most prominent effects (14). In addition, 
DHA decreases IL-1β secretion after palmitic acid induction (61), 
though these results were derived from a monocyte cell line, 
so cannot be directly compared with data from human blood 
derived DCs. Though the recent findings of Stelzner et al. (62) 
using LPS-stimulated MoDCs yield similar findings of palmitic 
acid induced increases in IL-1β and IL-6, although no effect of 
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oleic acid, along with no effect of human consumption of DHA 
and EPA rich capsules on cytokine secretion by PBMCs isolated 
from these subjects (63). Therefore, DHA inhibition of DC 
activation via PPARγ and retinoic X receptors (14) could explain 
the present findings of reductions in secretion of IL-6, although 
current evidence is limited due to very few studies being carried 
out to date.
The MeD Diet reduces resistin 
Production
Resistin concentration, after stimulation with LPS, R848, was 
significantly reduced from pre-intervention after a 1-year inter-
vention of a MED diet. This finding could be related to weight 
loss of the participants, as a recent study shows resistin levels 
positively correlate with BMI as well as abdominal visceral and 
subcutaneous fat volume and mass, determined by computer 
tomography (56). However, a weight loss study showed no effect 
on plasma resistin levels after a short term, 4-week reduced 
calorie diet, resulting in a mean weight loss of 3.4 kg (64). In 
addition, another group showed no association between plasma 
resistin levels and intra-abdominal fat levels, insulin sensitiv-
ity nor MetS, and only a weak association with BMI (65). The 
relationship between the adiposity and resistin levels is likely, 
therefore, to be complicated. The weight loss achieved by the 
participants in this study was small (−0.5 kg) and was not sig-
nificantly different between the two study groups, and therefore 
may not be causal in reducing resistin levels. This is especially 
apparent as the control group did not have a significant reduc-
tion in resistin at post-intervention. However, it should be noted 
that the CFB in resistin secretion was not significantly different 
between the two study groups.
We show that the MED diet consuming study participants 
consumed increased amounts of phenolic compounds, most 
likely from olive oil, consistent with elevated urinary HTS con-
centrations in this group. This suggests that the subjects were 
compliant in terms of increasing consumption of phenolic-rich 
foods, so the effects observed may be a consequence of altered 
dietary intake. In considering FA intake calculated form the 
self-report 7DD it is apparent that the MED-diet group con-
sumed significantly less saturated fat (P <  0.0001) compared 
with the control group while the MUFA and PUFA intakes 
were not significantly different between the groups (P = 0.063 
and 0.902, respectively; data not shown). The MUFA intake is 
decreased compared with baseline for both groups in this study, 
suggesting the effects observed may be attributed to changes 
in the SFA:MUFA or SFA:PUFA ratio, or simply the reduced 
intake of SFA.
Previous studies show that IL-6, TNF-α, and IL-1β can 
induce secretion of resistin and that the insulin sensitizer, 
rosiglitazone, can neutralize these cytokines by activating 
PPARγ (66), suggesting that the presence of low-grade chronic 
inflammation may enhance secretion of resistin in the elderly 
subjects in this study. Since in this study levels of IL-6, TNF-
α, and IL-1β were already low in the elderly subjects, and no 
significant reduction was observed after 1-year MED-diet 
intervention in any of these cytokines, the diet could potentially 
induce a reduction in resistin secretion via activation of PPARγ. 
However, the lack of a significant difference between the con-
trol and MED-diet groups for change in resistin production 
from baseline should be noted, while a significant reduction 
in TNF-α was observed between the two groups. The present 
findings therefore, in combination with those by Panda et  al. 
(39) using MoDCs, suggest that there may be an age-associated 
defect in the cytokine secretion pathways. n-3 PUFA or MUFA 
consumption could impact on cytokine signaling pathways and 
thus inhibit the secretion of resistin, as a consequence of the 
observed reduction in consumption of SFAs by the MED-diet 
intervention group and the confirmed intake of olive oil by the 
urinary HTS concentrations. Our study is however limited by 
the poor control group and therefore these data need validating 
in future studies with more stringent control over dietary intake 
and more frequent contact with the study participants. Since 
the dietary intervention was not blinded to the participants it is 
possible that both groups improved their diets, as a reduction 
in resistin has been correlated with the consumption of more 
nutritious diets (67, 68).
impact of Findings
The significant reduction in resistin production after the MED-
diet intervention is of biological relevance since elevated resistin 
is associated with insulin resistance, CVD risk and obesity (69). 
Therefore, if only 1 year of dietary change to increase consump-
tion of more phenolic-rich foods can reduce resistin levels to 
those observed in the healthy, young controls, this could have 
beneficial implications as a potential target for reducing the 
burden of these age-associated conditions. Further investigation 
into the mechanism for this reduction in resistin secretion would 
be of interest. This finding could also be relevant for the future 
investigation of drug targets to treat these conditions, such as 
the current pharmaceutical use of the PPARγ agonist [thiazo-
lidinedione (TZD)] to treat insulin resistance in patients with 
T2D, which is associated with numerous adverse side effects 
such as body weight gain, fluid retention, heart failure, bone 
fractures, and increased risk of bladder cancer (70). Patel et al. 
(71) show that expression of resistin by human macrophages can 
be reduced with extensive (96 h), but not short term (24 h), expo-
sure to rosiglitazone, which is a TZD. Thus, if the public could 
be persuaded to adopt aspects of the MED diet there may be 
potential for the age-associated increase in resistin, as seen here, 
to be prevented, and thus the need for such drugs to improve 
insulin sensitivity might be reduced.
In summary, the finding of age-associated impairments in 
DCs, and that dietary intervention reduced the age-associated 
increases in resistin secretion represents both methodological 
improvements and novel findings in the field of immunonutri-
tion and as such provides the basis for further investigation of 
the MED diet for immunomodulation, particularly in terms of 
increased adipokine secretion, with potential pharmaceutical 
implications.
recommendations for Future Work
To further validate our findings the next step includes testing the 
MED diet on antigen-specific immune responses in elderly sub-
jects. This could be achieved by taking blood samples, including 
15
Clements et al. DCs and Ageing with MED Diet
Frontiers in Nutrition | www.frontiersin.org December 2017 | Volume 4 | Article 65
serum, pre- and one postvaccination (72, 73) with for example, 
the seasonal influenza vaccine, after MED-diet intervention 
for 1 year. Vaccine antigen serum antibody levels and antigen-
specific memory T  cell recall responses could be measured 
and compared pre- and post-dietary intervention. The overall 
design of the Nu-AGE study could be improved through, for 
example, the use of multiple additional biomarkers to assess 
dietary compliance, and the collection of more frequent blood 
samples would have been advantageous in providing more data 
points and in demonstrating reproducibility of the results. The 
inclusion of a much more stringent control diet group would 
also be necessary, as well as more frequent contact with the 
MED-diet intervention subjects, with the provision of more of 
the food components to the subjects within the study center, to 
both encourage and monitor changes in dietary intake.
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